High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial.

Visalini Nair-ShallikerDavid P SmithVal GebskiManish I PatelMark FrydenbergJohn W YaxleyRobert GardinerDavid EspinozaMichael G KimlinMichael FenechDavid GillattHenry WooBruce K ArmstrongKrishan RasiahNader AwadJames SymonsHoward Gurney

Published in: BMJ open (2021)

ACTRN12616001707459.

Keyphrases

phase ii
prostate cancer
high dose
clinical trial
open label
study protocol
radical prostatectomy
randomized controlled trial
low dose
phase iii
stem cell transplantation
placebo controlled